Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
NEW YORK, Sept. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Compa
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
09:01pm, Saturday, 14'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 14, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
12:00pm, Saturday, 14'th Sep 2024
NEW YORK , Sept. 14, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2
Shareholders Are Invited To Help The Schall Law Firm In A Lawsuit Against DexCom, Inc. For Violating Securities Laws
11:00am, Saturday, 14'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "t
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
05:30am, Saturday, 14'th Sep 2024
Novo Nordisk is the leader in developing drugs in a fast-growing area. DexCom's recent drop doesn't take away from its long runway for growth.
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM
05:30pm, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 2
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
04:30pm, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
03:30pm, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Co
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM
11:30am, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In DexCom To Contact Him Directly To Discuss Their Options
DexCom Inc Is Being Sued For Possible Securities Fraud And The Schall Law Firm Urges Investors To Initiate Contact
11:00am, Friday, 13'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "t
Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM
07:20pm, Thursday, 12'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
RADNOR, PA / ACCESSWIRE / September 12, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom,
